RAS inhibitors not linked to increased risk of death from COVID-19
Concerns have been raised that the use of a common group of medications called RAS inhibitors could facilitate SARS-CoV-2 infection, impact COVID-19 disease severity and worsen prognosis. However, in a new nationwide registry-based ...
Nov 27, 2020
0
6